Notice Number: NOT-HL-11-123
Key Dates
Release Date: February 8, 2011
Application Deadline Date: May 1, 2011
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
In order to foster synergy and bring new expertise and resources to the NHLBI Progenitor Cell Biology Consortium, NHLBI is establishing funding for Ancillary/Collaborative Studies. Funds for Ancillary/Collaborative Studies have been set aside through the existing Administrative Coordinating Center, which will review and administer the applications as consortia agreements.
Background
RFA-HL-09-004 was released January 30, 2009 and the NHLBI Progenitor Cell Biology Consortium was established in the late Fall of 2009. The NHLBI Progenitor Cell Biology Consortium seeks to develop an improved understanding of the biology of stem and progenitor cells, and to harness this knowledge for the diagnosis and treatment of heart, lung, and blood diseases. The Consortium consists of multiple clusters, each forming a virtual Research Hub. In addition to interactions within Research Hubs, there is extensive collaboration between Hubs. The Consortium is supported by an Administrative Coordinating Center (ACC) to provide logistical support to the Consortium activities and the ACC is responsible for solicitation of applications for cores, pilot studies, and collaborative and ancillary studies. The ACC oversees the peer review and award of subcontracts under the guidance of an External Advisory Committee and NHLBI staff.
How to Apply
Additional information and application instructions (http://www.progenitorcells.org/docs/RFA-Anc-Coll.doc) can be found at the NHLBI Progenitor Cell Biology Consortium website, http://www.progenitorcells.org/. The application deadline is May 1, 2011.
Inquiries
For further information regarding the scientific goals of the Ancillary/Collaborative Studies and the NHLBI Progenitor Cell Biology Consortium, contact:
Denis Buxton, Ph.D.